Table 1 Baseline characteristics of individuals with RR-TB (mappable to clinic) in Western Cape, South Africa.

From: Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa

 

All (n = 6301)

XDR-TB only (n = 340)

Pre-XDR/XDR-TB (n = 1041)

RR-TB only (n = 5260)

Median

95% CI

Median

95% CI

Median

95% CI

Median

Median

Age (years)

34

19–55

33*

26–41*

33*

25–42*

34

27–43

 

n

%

n

%

n

%

n

%

Gender

Male

3419

54.3

179

52.6

565

54.3

2854

54.3

Female

2627

41.7

149

43.8

434

41.7

2193

41.7

Unknown

255

4.0

12

3.5

42

4.0

213

4.0

Smear status

Smear +

4293

68.1

270*

79.4*

827*

79.4*

3466

3466

TB diagnostic test

Xpert

2130

33.8

119

35.0

340

32.7

1790

34.0

Culture

2422

38.4

131

38.5

392

37.7

2030

38.6

Smear

1700

27.0

89

26.2

304

29.2

1396

26.5

RT-PCR

49

0.8

1

0.3

5

0.5

44

0.8

RR-TB diagnostic test

Xpert

2033

32.3

111

32.6

332

31.9

1701

32.3

LPA

4267

67.7

229

67.4

708

68.0

3559

67.7

DST

1

0.0

0

0.0

1

0.1

0

0.0

Second-line DST

Yes

5162

81.9

340*

100*

1041*

31.9*

4121

78.3

  1. *Significant p-value (XDR-TB group or pre-XDR/XDR group vs. RR-TB only) based on Wilcoxon t-test or Pearson chi-square test.
  2. LPA line probe assay, DST drug susceptibility testing, XDR-TB extensively drug-resistant tuberculosis, RR-TB rifampicin resistant tuberculosis.
Back to article page